Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Ranibizumab PDS Implant for Diabetic Retinopathy
Recruiting2 awardsPhase 3
The Woodlands, Texas
This trial is studying the effects of ranibizumab given through the Port Delivery System in people with diabetic retinopathy without center-involved diabetic macular edema.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.